Live news related to VALNEVA stock (FR0004056851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Goldman Sachs ajuste sa position sur Valneva ce vendredi 27 février 2026.
Valneva's stock fell by 2.26% this Thursday morning to €4.754, after closing at €4.86 the previous day. This corrective movement occurs in a context o…
Valneva has risen by 0.92% this Friday morning to 4.63 euros, following the announcement of its annual 2025 revenue. The stock has shown a sustained u…
The biopharmaceutical group Valneva has released its preliminary results for 2025, marked by stable revenue and strengthened cash reserves. The year 2…
Valneva's stock saw a significant increase this Thursday, driven by the release of its preliminary results for the fiscal year 2025. The stock rose by…
Goldman Sachs ajuste sa position sur Valneva ce jeudi 5 février 2026.
Valneva's stock recorded a 3.13% increase at midday on Wednesday, February 4, 2026, reaching 4.026 euros. The biotech company, specializing in vaccine…
Valneva SE and the Instituto Butantan announce the initiation of a pilot vaccination campaign in Brazil using IXCHIQ®, a single-dose vaccine against c…
Valneva, a French vaccine specialist, closed the week at 3.89 euros, marking a decline of 11.35%. This correction follows an annual increase of 64.61%…
Valneva's stock closed the session on Wednesday, January 28, 2026, at 3.99 euros, down by 2.45% compared to the previous day. This decline is part of …
